Clinicians & Researchers

You are here

PETAL Network Bibliography

Export 55 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group.  2022.  Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial.. Lancet Infect Dis. 22(5):622-625.
Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, D Files C et al..  2021.  A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.. N Engl J Med. 384(10):905-914.
Rogers AJ, Wentworth D, Phillips A, Shaw-Saliba K, Dewar RL, Aggarwal NR, Babiker AG, Dharan NJ, Davey VJ, Higgs ES et al..  2022.  The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.. Ann Intern Med. 175(10):1401-1410.
Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM et al..  2022.  Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.
ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group.  2022.  Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial.. Lancet Respir Med. 10(10):972-984.
Admon AJ, Iwashyna TJ, Kamphuis LA, Gundel SJ, Sahetya SK, Peltan ID, Chang SY, Han JH, Vranas KC, Mayer KP et al..  2023.  Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 Months.. JAMA Netw Open. 6(2):e2255795.
Aggarwal NR, Brower RG, Hager DN, Thompson BT, Netzer G, Shanholtz C, Lagakos A, Checkley W, Investigators NInstitutes.  2017.  Oxygen Exposure Resulting in Arterial Oxygen Tensions Above the Protocol Goal Was Associated with Worse Clinical Outcomes in Acute Respiratory Distress Syndrome.
Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR et al..  2021.  Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
B
Baron RM, Christman JW, Liu KD, Matthay MA, Self WH, McVerry BJ, Hite RDuncan, Paine R, Wurfel MM, Shapiro NI et al..  2020.  Monitoring Research Blood Sampling in Critically Ill Patients: Avoiding Iatrogenic Anemia.. Am J Respir Crit Care Med. 202(6):885-887.
Beitler JR, Malhorta A, Thompson BT.  2016.  Ventilator-induced Lung Injury.
Benthin C, Pannu S, Khan A, Gong M.  2016.  The Nature and Variability of Automated Practice Alerts Derived from Electronic Health Records in a U.S. Nationwide Critical Care Research Network.. Ann Am Thorac Soc. 13(10):1784-1788.
Berger JS, Neal MD, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Althouse AD, Lawler PR, McVerry BJ, Kim KS et al..  2023.  Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.. JAMA Netw Open. 6(5):e2314428.
Berger JS, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Cheng Y, McVerry BJ, Kim KS, Lopes RD, Atassi B et al..  2022.  Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.. JAMA. 327(3):227-236.
Brown SM, Duggal A, Tidswell M, Khan A, Exline M, Park PK, Schoenfeld DS, Liu M, Grissom CK, Moss M et al..  2017.  Nonlinear Imputation of PaO2/FIO2 From SpO2/FIO2 Among Mechanically Ventilated Patients in the ICU: A Prospective, Observational Study.. Critical Care Medicine. 45(8):1317-1324.
Brown SM, Grissom CK, Moss M, Rice TW, Schoenfeld D, Hou P, B Thompson T, Brower RG.  2016.  Non-linear imputation of PaO2/FIO2 from SpO2/FIO2 among patients with Acute Respiratory Distress Syndrome.. Chest.

Pages